Found 372 clinical trials
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Advanced Head and Neck Squamous Cell Carcinoma
People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Northwell Health.
- 55 views
- 27 Jun, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Advanced Head and Neck Squamous Cell Carcinoma
People with head and neck squamous cell carcinoma may be eligible to participate in a research study being conducted by Montefiore Medical Center.
- 24 views
- 20 May, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Photoimmunotherapy – Head and Neck Squamous Cell Carcinoma
People with head and neck squamous cell carcinoma are asked to participate in a research study being conducted by Northwell Health.
- 87 views
- 20 Feb, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
INDUCE-3 - Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
People with Head and Neck Squamous Cell Carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.
- 25 views
- 01 May, 2020
- 1 location
-
Phase 2 trial
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- 612 views
- 08 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
than 35 year, in complete remission 2-4 months after treatment of head and neck squamous cell carcinoma Patients will be randomized after the post-treatment check-up (clinical examination and reference
- 0 views
- 23 Feb, 2020
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Recombinant human endostatin adenovirus injection is a novel anti-tumor gene therapy drug. E10A contains a recombinant human endostatin gene with the second-generation recombinant adenovirus as its vector. After transfection tumor cells. E10A expresses human endostatin, which inhibits vascular endothelial cell proliferation and tumor angiogenesis, and blocks tumor blood supply, thereby …
- 0 views
- 08 Nov, 2020
- 1 location
-
Multi-country trial
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial
The aim of the study is to test whether a resource-sparing 4-week, 20-fraction course of accelerated hypofractionated radiotherapy is non-inferior to accelerated radiotherapy delivering 33 fractions over 5.5 weeks in the treatment of patients with Stage I-IV squamous cell carcinoma of the pharynx, larynx and oral cavity with the exception …
- 15 views
- 11 Aug, 2019
- 2 locations
-
Multi-country trial
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
A Study to Determine the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
tilsotolimod, nab-paclitaxel, and ABBV-181 in participants with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
- 22 views
- 24 Dec, 2020
- 42 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
/M) head and neck squamous cell carcinoma/cancer (HNSCC). This is a randomized, double-blind, adaptive Phase II/III study comparing a combination of GSK3359609 inducible T cell co-stimulatory
- 6 views
- 17 Jan, 2021
- 177 locations